24 Nations, One Standard — India’s Pharmacopoeia Goes Global

Date:

Share post:

The Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding with Lao PDR’s Food and Drug Department and Ministry of Health, marking a significant step in India’s growing influence over global medicine quality standards.

The agreement was formalized at the 10th India–Lao PDR Joint Commission Meeting, co-chaired by External Affairs Minister Dr. S. Jaishankar, underscoring the strategic depth of bilateral healthcare ties.

With Lao PDR onboard, the Indian Pharmacopoeia now holds formal recognition across 24 countries — a testament to the world’s growing confidence in India’s regulatory and scientific frameworks.

This milestone reinforces India’s position as a trusted global authority in ensuring medicines are safe, effective, and quality-assured.

India is not just manufacturing medicines for the world — it is now setting the standard for them.

Written by: Sharon Bose & Arundhuti Chatterjee

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Johnson & Johnson to acquire Firefly Bio to advance novel cancer treatment

Johnson & Johnson  announced that it has entered into a definitive agreement to acquire Firefly Bio, Inc., a...

Emergency Price Adjustment Approved for Critical Cancer Drugs Amid Raw Material Crisis

In a decisive move to counter critical domestic medicine shortages caused by global macroeconomic headwinds, the Department of...

India Targets 100 New Biologic Medicines by 2047 Under Biopharma SHAKTI

At the landmark 2nd Pharma Summit & Awards 2026 organized by the Associated Chambers of Commerce and Industry...

Investors Show Strong Interest in Hexagon Nutrition IPO, Bids Reach 54 Times

Hexagon Nutrition Limited, a leading research-driven nutrition company, concluded its Initial Public Offering (IPO) with resounding success, achieving...